Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Seifert

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Nucleic Acids Research|April 29, 2014
Identification and characterization of RNA guanine-quadruplex binding proteinsAnnekathrin von Hacht, Oliver Seifert, Marcus Menger, et al.
Mabs|April 12, 2016
An optimized antibody-single-chain TRAIL fusion protein for cancer therapyMartin Siegemund, Oliver Seifert, Maria Zarani, et al.
Mabs|March 23, 2021
A bivalent, bispecific Dab-Fc antibody molecule for dual targeting of HER2 and HER3Alexander Rau, Katharina Kocher, Mirjam Rommel, et al.
Engineering in Life Sciences|May 5, 2025
Design of a Biocatalytic Filter for the Degradation of Diclofenac and Its Ozonation ProductsDorothee Schmiemann, Jessica Schneider, Marcel Remek, et al.
Mabs|April 20, 2017
Inhibition of HER3 activation and tumor growth with a human antibody binding to a conserved epitope formed by domain III and IVLisa C Schmitt, Alexander Rau, Oliver Seifert, et al.
Acta Dermato-Venereologica|May 14, 2016
Transforming Growth Factor Beta Gene Signatures are Spatially Enriched in Keloid Tissue Biopsies and Ex vivo-Cultured Keloid FibroblastsAdam Taylor, David C Budd, Barbara Shih, et al.
Mabs|May 19, 2026
Novel bispecific T-cell engagers overcoming acquired EGFR resistanceLennart Kühl, Ann-Kathrin Löffler, Oliver Seifert, et al.
Biomaterials|March 2, 2015
Tailoring the stealth properties of biocompatible polysaccharide nanocontainersBiao Kang, Patricia Okwieka, Susanne Schöttler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2020
OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor ModelsMyriam Fabre, Cristina Ferrer, Saioa Domínguez-Hormaetxe, et al.
Viruses|November 25, 2023
Evaluation of the Neutralizing Antibody STE90-C11 against SARS-CoV-2 Delta Infection and Its Recognition of Other Variants of ConcernsLeila Abassi, Federico Bertoglio, Željka Mačak Šafranko, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Nucleic Acids Research|April 29, 2014
Identification and characterization of RNA guanine-quadruplex binding proteinsAnnekathrin von Hacht, Oliver Seifert, Marcus Menger, et al.
Mabs|April 12, 2016
An optimized antibody-single-chain TRAIL fusion protein for cancer therapyMartin Siegemund, Oliver Seifert, Maria Zarani, et al.
Mabs|March 23, 2021
A bivalent, bispecific Dab-Fc antibody molecule for dual targeting of HER2 and HER3Alexander Rau, Katharina Kocher, Mirjam Rommel, et al.
Engineering in Life Sciences|May 5, 2025
Design of a Biocatalytic Filter for the Degradation of Diclofenac and Its Ozonation ProductsDorothee Schmiemann, Jessica Schneider, Marcel Remek, et al.
Mabs|April 20, 2017
Inhibition of HER3 activation and tumor growth with a human antibody binding to a conserved epitope formed by domain III and IVLisa C Schmitt, Alexander Rau, Oliver Seifert, et al.
Acta Dermato-Venereologica|May 14, 2016
Transforming Growth Factor Beta Gene Signatures are Spatially Enriched in Keloid Tissue Biopsies and Ex vivo-Cultured Keloid FibroblastsAdam Taylor, David C Budd, Barbara Shih, et al.
Mabs|May 19, 2026
Novel bispecific T-cell engagers overcoming acquired EGFR resistanceLennart Kühl, Ann-Kathrin Löffler, Oliver Seifert, et al.
Biomaterials|March 2, 2015
Tailoring the stealth properties of biocompatible polysaccharide nanocontainersBiao Kang, Patricia Okwieka, Susanne Schöttler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2020
OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor ModelsMyriam Fabre, Cristina Ferrer, Saioa Domínguez-Hormaetxe, et al.
Viruses|November 25, 2023
Evaluation of the Neutralizing Antibody STE90-C11 against SARS-CoV-2 Delta Infection and Its Recognition of Other Variants of ConcernsLeila Abassi, Federico Bertoglio, Željka Mačak Šafranko, et al.
Pageof 9